Evidence map›Paper›PMID 35893103›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Treatment-Limiting Decisions in Patients with Spontaneous Intracerebral Hemorrhage.

Felix Lehmann, Matthias Schneider, Joshua D Bernstock, Christian Bode, Valeri Borger, Stefan Felix Ehrentraut, Florian Gessler, Anna-Laura Potthoff, Christian Putensen, Lorena M Schenk and 4 more

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Felix LehmannDepartment of Anesthesiology and Intensive Care, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0003-2847-9271
Matthias SchneiderDepartment of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-6025-7479
Joshua D BernstockDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-7814-3867
Christian BodeDepartment of Anesthesiology and Intensive Care, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-0830-870X
Valeri BorgerDepartment of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-5905-4121
Stefan Felix EhrentrautDepartment of Anesthesiology and Intensive Care, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0001-5747-6737
Florian GesslerDepartment of Neurosurgery, University Hospital Rostock, 18057 Rostock, Germany.ORCID 0000-0002-3471-0575
Anna-Laura PotthoffDepartment of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany.
Christian PutensenDepartment of Anesthesiology and Intensive Care, University Hospital Bonn, 53127 Bonn, Germany.
Lorena M SchenkDepartment of Anesthesiology and Intensive Care, University Hospital Bonn, 53127 Bonn, Germany.
Julian ZimmermannDepartment of Neurology, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0003-1964-0078
Hartmut VatterDepartment of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany.
Patrick SchussDepartment of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-5806-2576
Alexis HadjiathanasiouDepartment of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-5477-8518
University Hospital Bonn · DEBrigham and Women's Hospital · USUniversity of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Treatment-limiting decisions (TLDs) are employed to actively withhold treatment/invasive interventions from patients in whom clinicians feel they would derive little to no benefit and/or suffer detrimental effects. Data regarding the employment of TLDs in patients with spontaneous intracerebral hemorrhage (ICH) remain sparse. Accordingly, this study sought to investigate both the prevalence of TLDs and factors driving TLDs in patients suffering from spontaneous ICH. Materials and Methods: This was a retrospective study of 249 consecutive patients with ICH treated from 2018−2019 at the Neurovascular Center of the University Hospital Bonn. Reasons deemed critical in the decision-making process with regard to TLD were ultimately extracted/examined via chart review of qualifying patients. Results: A total of 249 patients with ICH were included within the final analyses. During the time period examined, 49 patients (20%) had advanced directives in place, whereas in 53 patients (21%) consultation with relatives or acquaintances was employed before further treatment decisions. Overall, TLD ultimately manifested in 104 patients (42%). TLD was reached within 6 h after admission in 52 patients (50%). Congruent with severity of injury and expected outcomes, TLDs were more likely in patients with signs of cerebral herniation and an ICH score > 3 (p < 0.001). Conclusions: The present study examines details associated with TLDs in patients with spontaneous ICH. These data provide insight into key decisional processes and reinforce the need for further structured investigations in an effort to help guide patients and their families.

Indexed as

Cerebral HemorrhageHumansRetrospective Studiesadvanced directivesintracerebral hemorrhage (ICH)treatment futilitytreatment-limiting decisions (TLD)

Identifiers

PMID35893103
PMCPMC9332709
OpenAlexW4287833026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.